FindTrial
Sign In

Research on N6-methyladenosine regulation mechanism in Calcific aortic valve disease

Research on N6-methyladenosine regulation mechanism in Calcific aortic valve disease

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2000040745
Enrollment
Unknown
Registered
2020-12-08
Start date
2020-12-08
Completion date
Unknown
Last updated
2021-03-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Calcific aortic valve disease

Interventions

Case series:No

Sponsors

Tianjin Chest Hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: The patient was diagnosed with aortic valve stenosis before the operation. The echocardiogram showed thickening of the aortic valve, strong echo or high-density calcification clusters attached to the valve, and postoperative pathological results showed calcification deposits.

Exclusion criteria

Exclusion criteria: Rheumatic aortic valve disease, congenital valvular disease, and infective endocarditis

Countries

China

Contacts

Public ContactNan Jiang

Tianjin Chest Hospital

m15233622238@163.com+86 022-88185081

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026